Clinical Trials on Response of Fatty Acid Desaturation to Zinc Intake in Portugal
Total 0 results
Nothing found
Sponsors and Collaborators
- Universidad de Ciencias Empresariales y Sociales
- NED University of Engineering and Technology
- Maria de Lourdes de Sousa Maia, MD
- Iuppa Industriale S.r.l.
- National Cancer Imaging Translational Accelerator
- Horizon Pharma USA, Inc.
- Fundación Salutia
- Colorado State University Extension-La Plata County
- Grin Eye Care
- Meander Medisch Centrum
- Öğr. Gör. Ali GÜZEL
- For Ever Fabien
- Neurological Research Center
- Y.S.P. Industries (M) Sdn. Bhd, Menara LGB, Taman Tun Dr Ismail, 60000 Kuala Lumpur, Malaysia
- Research Center for Clinical Neuroimmunology and Neuroscience Basel
- The Adam Practice, Dorset
- Piotr Chlosta
- DILEK SAYIK
- Frankfurter Institut für Klinische Krebsforschung IKF GmbH
- Immunis, Inc.
- View Full List
Medical Conditions
- Multiple Conditions
- Otitis
- Neurological Diseases, Heart or Respiratory Failure,
- Health Care Worker
- Nasal High-frequency Oscillatory Ventilation
- Allogeneic, Hematopoietic Cell Transplant (HCT)
- Oral Sulfate Solution
- Stage III Lung Small Cell Carcinoma AJCC v7
- Rhinitis, Allergic, Nonseasonal
- Alcohol Abuse in Pregnancy
- Groin Node
- Lymphocyte Subsets in Women of Child-bearing Age
- Normal Sinus Rhythm With 2 or 3° AV or BBB Block
- Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)
- Orthopaedic Injuries
- Hyperosmolality
- Raynaud Secondary to Other Autoimmune Disease
- Cancer of Lung, Kidney or Liver
- Trypanosoma Brucei Rhodesiense; Infection
- Headache, Intractable
- View Full List
Drug Interventions
- Valette
- Stillen® Tab
- Ciprodex (R)
- Irinotecan
- Benzocaine Gel
- Multiple PET/MRI with Gallium-68 labeled PSMA-HBED-CC
- Budigalimab
- Cyclophosphamide
- Dexamethasone
- AZD1305
- OROS methylphenidate hydrochloride
- 1 mg of transdermal estradiol daily and 10mg of oral MPA
- Fumaric acids
- POLAT-001
- TPN171H 10mg
- ATV/r plus ABC/3TC
- Voriconazole low dose
- Drug A (Blinded Drug)
- Schedule Finding Triplet: Combination of NKTR-214+ nivolumab+ ipilimumab
- [18F]-JNJ-64413739
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Canada
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Ghana
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Liberia
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Panama
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Uruguay
- CRO list by country